177Lu-PSMA-3Q

N/A

Report date: 2025/11/20 16:02:20

NME

Base Information

Drug Name177Lu-PSMA-3Q

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe First Medical Center Of Chinese People'S Liberation Army General Hospital

China Registration ClassN/A

Develop Information

Active CompaniesThe First Medical Center Of Chinese People'S Liberation Army General Hospital

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A